Literature DB >> 35008058

Epidemiological Characteristics and Risk Factors Related to Drug-resistant Tuberculosis in Luanda, Angola.

Cruz S Sebastião1,2,3, João Samulengo1, Euclides Sacomboio1,3, Ngiambudulu M Francisco1, Carlos Teixeira1, Samuel António1, Mizele Kinanga4, Zoraima Neto1, Joana Paixão1, António Mateus1, Zinga David1, Jocelyne Neto de Vasconcelos1,2, Joana Morais1,5.   

Abstract

Tuberculosis (TB) is a major cause of illness and public health concern, especially in resource-limited countries. This study analyzed the characteristics related to anti-TB drug resistance. Moreover, we examined the evidence-based indications for the treatment of active TB in Angola. This study evaluated the medical records of 176 patients screened for TB from January to September 2016 in Luanda, the capital city of Angola. Approximately 66.5% of the patients were newly diagnosed with active TB. The residence area showed a significant relationship with TB (P = 0.025), whereas age group (P = 0.272), gender (P = 0.853), and HIV status (P = 0.284) did not showed any relationship with TB. Overall, 72.4% of TB patients had resistance to at least one of the anti-TB drugs. The risk of anti-TB drug resistance was higher in males (odds ratio [OR]: 1.22; 95% confidence interval [CI]: 0.42-3.58, P = 0.685] and in TB-HIV coinfected patients [OR: 1.39; (95% CI: 0.26-7.28), P = 0.700], whereas it was lower in patients aged 30 years or older (OR: 0.56; 95% CI: 0.18-1.69) P = 0.303) and in patients living in urbanized areas (OR: 0.74; 95% CI: 0.17-3.25; P = 0.685). Our findings showed that drug-resistant TB is emerging in Angola. Further studies on factors related to anti-TB drug resistance are urgently needed to ascertain the magnitude of the problem and to proffer strategies toward TB control in Angola.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35008058      PMCID: PMC8922512          DOI: 10.4269/ajtmh.21-0659

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  28 in total

1.  Prevalence and risk factors of multidrug-resistant tuberculosis in Cubal, Angola: a prospective cohort study.

Authors:  M L Aznar; A Rando-Segura; M M Moreno; M E Soley; E S Igual; C Bocanegra; E G Olivas; A Ninda Eugénio; A Zacarias; D Katimba; E Gabriel; J Mendioroz; M T López García; T P Suñe; M T Tórtola Fernández; I Molina Romero
Journal:  Int J Tuberc Lung Dis       Date:  2019-01-01       Impact factor: 2.373

2.  Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhiça.

Authors:  S Valencia; D Respeito; S Blanco; R M Ribeiro; E López-Varela; V G Sequera; B Saavedra; E Mambuque; M Gómez Morillo; H Bulo; F Cobelens; E Macete; P L Alonso; J A Caminero; A L García-Basteiro
Journal:  Int J Tuberc Lung Dis       Date:  2017-04-01       Impact factor: 2.373

Review 3.  Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.

Authors:  Sebastian M Gygli; Sonia Borrell; Andrej Trauner; Sebastien Gagneux
Journal:  FEMS Microbiol Rev       Date:  2017-05-01       Impact factor: 16.408

4.  Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan.

Authors:  Abdul Majeed Akhtar; Muhammad Awais Arif; Shamsa Kanwal; Sadia Majeed
Journal:  J Pak Med Assoc       Date:  2016-08       Impact factor: 0.781

5.  Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study.

Authors:  N Lomtadze; R Aspindzelashvili; M Janjgava; V Mirtskhulava; A Wright; H M Blumberg; A Salakaia
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

6.  The Diagnosis and Treatment of Tuberculosis.

Authors:  Isabelle Suárez; Sarah Maria Fünger; Stefan Kröger; Jessica Rademacher; Gerd Fätkenheuer; Jan Rybniker
Journal:  Dtsch Arztebl Int       Date:  2019-10-25       Impact factor: 5.594

Review 7.  The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era.

Authors:  Katherine Floyd; Philippe Glaziou; Alimuddin Zumla; Mario Raviglione
Journal:  Lancet Respir Med       Date:  2018-04       Impact factor: 30.700

8.  Drug susceptibility patterns of the Mycobacterium tuberculosis isolated from previously treated and new cases of pulmonary tuberculosis at German-Nepal tuberculosis project laboratory, Kathmandu, Nepal.

Authors:  Gobinda Thapa; Narayan Dutt Pant; Saroj Khatiwada; Binod Lekhak; Bhawana Shrestha
Journal:  Antimicrob Resist Infect Control       Date:  2016-08-31       Impact factor: 4.887

Review 9.  Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.

Authors:  Baba Maiyaki Musa; Aishatu L Adamu; Najibah A Galadanci; Bashir Zubayr; Chisom N Odoh; Muktar H Aliyu
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

Review 10.  What We Know About Tuberculosis Transmission: An Overview.

Authors:  Gavin Churchyard; Peter Kim; N Sarita Shah; Roxana Rustomjee; Neel Gandhi; Barun Mathema; David Dowdy; Anne Kasmar; Vicky Cardenas
Journal:  J Infect Dis       Date:  2017-11-03       Impact factor: 7.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.